68Ga-PSMA-PET在前列腺癌根治性外照射后生化失败中的病灶定位
研究纳入419例接受剂量递增图像引导外照射(78或82Gy)的前列腺癌患者,中位随访50个月,70例(17%)出现生化失败(nadir+2)。50例候选者中48例行68Ga-PSMA-PET,扫描全部阳性;52%的阳性扫描病灶位于前列腺外,仅17%为孤立局部复发,占全部419例的2%。结论提示剂量递增外照射后生化失败的部位以远处为主。
要点
- 419例中70例(17%)出现生化失败,48例行PSMA扫描且全部阳性。
- 48例阳性扫描中25例(52%)失败位于前列腺外,8例(17%)为孤立局部复发。
- 孤立局部复发仅占全部419例的2%,提示失败部位以远处为主。
核心结论
- 剂量递增外照射后生化失败患者PSMA扫描全部阳性,失败部位总体以远处为主。
- PSMA定义的孤立局部复发仅见于419例中的8例(2%)。
研究设计与样本
- 2007至2014年间538例男性接受图像引导外照射,剂量为78或82Gy。
- 外照射后至少24个月且生化失败(nadir+2)者接受PSMA扫描,最终419例组成研究队列。
- 中位随访50个月,70例(17%)出现生化失败。
主要发现
- 57例存活生化失败者中5例常规扫描检出转移,2例失访。
- 50例候选者中48例行PSMA扫描,全部 unequivocally 阳性。
- 48例阳性扫描中25例(52%)失败位于前列腺外:骨5例、淋巴结16例、两者兼有3例、肺1例。
- 8例(17%)为孤立局部复发,占全部419例的2%。
临床怎么用
- 对根治性外照射后生化失败者可行68Ga-PSMA-PET定位复发灶,本研究中该扫描全部阳性。
- 扫描结果提示失败多在前列腺外,孤立局部复发比例低,可能影响 salvage 治疗决策。
局限性
- 研究为单中心队列,PSMA扫描仅用于生化失败候选者中的48例。
- 57例存活生化失败者中2例失访,5例常规扫描已检出转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We investigated the role of 68Ga-PSMA-PET (PSMA) to determine the location of disease recurrence in those with a rising PSA following definitive external beam radiation treatment (EBRT). MATERIALS AND METHODS: 538men were treated with image guided EBRT to a dose of 78 or 82Gy between 2007 and 2014. Patients at least 24months post EBRT with biochemical failure (nadir+2) underwent PSMA scanning. Local recurrence (LR) was defined as increased uptake within the prostate or seminal vesicles. Distant disease included lymph node (LN), bone or visceral metastases. RESULTS: 419men formed the study cohort. Median follow-up was 50months, 70 patients (17%) had biochemical failure (BF), 13 of whom have died. Of the 57 survivors, 5 had metastases detected on conventional scans; 2 were lost to follow up. 48men (of 50 candidates) underwent PSMA; in all cases, the PSMA was unequivocally positive. Of the 48 positive scans, 25 patients (52%) failed beyond the prostate - 5 in bones, 16LN, 3 in both, and 1 in the lungs. Fifteen men (31%) failed within the gland and in either LN (11), bones (3), or both (1). Eight (17%) had an isolated LR, which represents 2% of patients managed with definitive EBRT and followed for at least 2years. CONCLUSIONS: PSMA was positive in all patients with BF. Site of failure following dose-escalated EBRT was generally distant. Isolated LR (on PSMA) occurred in only 8 of 419 patients post-EBRT.
引用
- Hruby G, Eade T, Kneebone A, et al. Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer. Radiother Oncol. 2016. PMID: 28040309. doi:10.1016/j.radonc.2016.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。